Direct Intraesophageal Growth from Metastatic Mediastinal Lymphadenopathy in Thymic Carcinoma-Reference-Cited by-同舟云学术

Direct Intraesophageal Growth from Metastatic Mediastinal Lymphadenopathy in Thymic Carcinoma

Published:2021-03-15 Issue:6 Volume:60 Page:923-926
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kanazawa Hiroki¹,Sasaki Nobukazu¹,Kobayashi Takashi²,Fukushima Toshirou²,Kanda Shintaro²,Koizumi Tomonobu²,Iwaya Mai³

Affiliation:

1. Second Department of Internal Medicine, Shinshu University School of Medicine, Japan

2. Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Japan

3. Department of Centarl Laboratory, Shinshu University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/6/60_5501-20/_pdf

Reference12 articles.

1. 1. Hsu CP, Chen CY, Chen CL, Hsu NY, Wang JH, Wang PY. Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 107: 615-620, 1994.

2. 2. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76: 878-885, 2003.

3. 3. Weksler B, Dhupar R, Parikh V, Nason KS, Pennathur A, Ferson PF. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 95: 299-303, 2013.

4. 4. Ko R, Shukuya T, Okuma Y, et al. Prognostic factors and efficacy of first-line chemotherapy in patients with advanced thymic carcinoma: a retrospective analysis of 286 patients from NEJ023 study. Oncologist 23: 1210-1217, 2018.

5. 5. Yano M, Sasaki H, Yokoyama T, et al. Thymic carcinoma 30 cases at a single institution. J Thoracic Oncol 3: 265-269, 2008.